Effect of (E)-5-(2-bromovinyl)-2′-deoxyuridine on life-span and 5-fluorouracil metabolism in mice with hepatic metastases
- 31 December 1990
- journal article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 26 (10) , 1089-1092
- https://doi.org/10.1016/0277-5379(90)90058-2
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Enhancing effect of bromovinyldeoxyuridine on antitumor activity of 5-fluorouracil and ftorafur against adenocarcinoma 755 in miceEuropean Journal of Cancer and Clinical Oncology, 1987
- Enhancing effect of bromovinyldeoxyuridine on antitumour activity of 5-fluorouracil in mice bearing MOPC-315 plasmacytomasBritish Journal of Cancer, 1986
- Regeneration of the antivirel drug(E)-5-(2-bromovinyl)-2′ -deoxyuridinein vivoNucleic Acids Research, 1984
- Experimental model for liver metastasis formation using lewis lung tumorZeitschrift für Krebsforschung und Klinische Onkologie, 1982
- Nonlinear pharmacokinetic models for 5-fluorouracil in man: Intravenous and intraperitoneal routesClinical Pharmacology & Therapeutics, 1980
- Metabolic fate of 1-hexylcarbamoyl-5-fluorouracil after oral administration in miceXenobiotica, 1980
- Use of o-phthalaldehyde for detection of amino acids and peptides on thin-layer chromatogramsJournal of Chromatography A, 1976
- Studies on fluorinated pyrimidines: VII—the degradative pathwayBiochemical Pharmacology, 1959